As far as the long-term mortality following an acute ischemic stroke is concerned, Tu et al. [34], having examined 4125 stroke patients, demonstrated the prognostic potential of copeptin in predicting all-cause death or cardiovascular disease (CVD) mortality during a follow-up period of 1-year poststroke. This evidence concerns the gene AVP and Stroke.